Nab-paclitaxel (nab-P) combined with FOLFOX for advanced pancreatic cancer: A phase I study
| Autor: | Kalyan Mantripragada, Kenneth D. Bishop, Kayla Rosati, Lynn Shaw, Trevor Clark Austin, Kristen Mitchell, Kimberly Perez, Lindsay Houlihan, Alise Lombardo, Howard Safran, Kevin P. Charpentier, Diane Martel |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Oncology
Cancer Research medicine.medical_specialty FOLFIRINOX business.industry medicine.disease digestive system diseases Gemcitabine Phase i study Irinotecan stomatognathic diseases FOLFOX Pancreatic cancer Internal medicine Medicine heterocyclic compounds business therapeutics neoplasms Nab-paclitaxel medicine.drug |
| Zdroj: | Journal of Clinical Oncology. 32:4123-4123 |
| ISSN: | 1527-7755 0732-183X |
| DOI: | 10.1200/jco.2014.32.15_suppl.4123 |
| Popis: | 4123 Background: The contribution of irinotecan to the efficacy of FOLFIRINOX in pancreatic cancer is uncertain. The addition of irinotecan to gemcitabine was not superior to gemcitabine alone in p... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|